Referências Bibliográficas

1.  Diretrizes da Sociedade Brasileira de Diabetes 2019-2020. Práticas seguras para preparo e aplicação de insulina. São Paulo: ACFarmacêutica; 2019; p. 189-. [REF-24256]
O que é Diabetes? Sociedade Brasileira de Endocrinologia e Metabologia – SBEM, 2021. [REF-24256];

2. ANVISA – Agência Nacional de Vigilância Sanitária. RESOLUÇÃO – RE N° 2605, DE 11 DE AGOSTO DE 2006. Lista de produtos médicos enquadrados como de uso único proibidos de ser reprocessados. [REF-33282];

3. American Association Diabetes Educators. An effective model of diabetes care and education. Revising the AADE-7 self-care behaviors®. Chicago. 2020;46(2):139-60;

4. Pen Needle Compatibility Status Summary with Diabetes Care & Non-Diabetes Drug Delivery Devices. Document Number: 149OTH-0004-20 Rev X – Dated: 30th May 2025;

5. Frid AH, et al. New Insulin Delivery Recommendations. Mayo Clinic Proceedings. 2016;91(9):1231–1255;

6. Gibney MA, Arce CH, Byron KJ, Hirsch LJ. Skin and subcutaneous adipose layer thickness in adults with diabetes at sites used for insulin injections: implications for needle length recommendations. Curr Med Res Opin 2010;26:1519-30;

7. Aronson R, Gibney MA, Oza K, et al. Insulin pen needles: effects of extra-thin wall needle technology on preference, confidence, and other patient ratings. Clin Ther. 2013;35(7):923-933;

8. Hirsch L, Gibney M, Berube J, Manocchio J. Impact of a modified needle tip geometry on penetration force as well as acceptability, preference, and perceived pain in subjects with diabetes. J Diabetes Sci Technol. 2012;6(2):328-335.